Blog

Keep up with the latest from R&D Partners.

BioSpace Launches 2022 Hotbed Maps to Highlight Thriving Life Sciences Clusters

BioSpace Launches 2022 Hotbed Maps to Highlight Thriving Life Sciences Clusters

Via: https://www.biospace.com/article/biospace-launches-2022-hotbed-maps-to-highlight-thriving-life-sciences-clusters/ Published: Jan 18, 2022 By Heather McKenzie Featuring nine of the most important regions in the life sciences industry, BioSpace’s Hotbed Maps are the guide employees and investors across the sector look to in order to chart its trajectory. The unique, original watercolor artistry

Read More »
Clinical Catch-Up: January 10-14

Clinical Catch-Up: January 10-14

Via: https://www.biospace.com/article/clinical-catch-up-january-10-14/ Published: Jan 17, 2022 By Mark Terry Heading into the middle of January, companies announced plenty of new clinical trial news. Here’s a look. COVID-19-Related Ocugen announced that its development partner, India’s Bharat Biotech, published positive data from a Phase II trial of the vaccine candidate

Read More »
Clinical Catch-Up: December 11-17

Clinical Catch-Up: December 11-17

Via: https://www.biospace.com/article/clinical-catch-up-december-11-17/ Published: Dec 20, 2021 By Mark Terry It was an enormously busy week with plenty of announcements from the American Society of Hematology (ASH) meeting and numerous companies working to get the news out ahead of the holidays and year-end. Here’s a look: COVID-19-Related

Read More »

Life Sciences Global Expansions: New Sites, Bigger Facilities, More Jobs

Via: https://www.biospace.com/article/life-sciences-companies-expand-operations-across-the-globe/ Published: Dec 17, 2021 By Alex Keown As 2021 nears an end, biopharma companies are eying the establishment of new toeholds and facilities across the globe that will bolster their commercial and manufacturing strategies. BioSpace rounds up some of the latest announcements. Pfizer Builds

Read More »
Life Sciences Expansions Take Off as 2021 Wraps Up

Life Sciences Expansions Take Off as 2021 Wraps Up

Via: https://www.biospace.com/article/life-science-companies-announce-expansion-plans-as-they-wrap-up-2021 Published: Dec 08, 2021 By Mark Terry Several life sciences companies and life science-focused real estate firms have announced expansion plans as 2021 comes to an end. Here’s a look: Novavax to Expand Maryland Campus Novavax, on the cusp of getting its COVID-19 vaccine

Read More »

“Fourth Wave” Driven Primarily by Delta and New Omicron Data

Via: https://www.biospace.com/article/omicron-is-worrisome-but-delta-is-a-problem-right-now-and-other-covid-19-stories/ Dec 03, 2021 By Mark Terry Two years into the COVID-19 pandemic and countries are reporting what might be called the fourth wave of rising cases, driven mainly by the Delta variant, although Omicron has everybody concerned. Here’s a look. Omicron Variant At Least

Read More »
6 Reasons to Decline a Counter Job Offer

6 Reasons to Decline a Counter Job Offer

Counteroffers often result when your employer suspects they may be losing a talented employee. They are all of a sudden hit with this reality – there’s something that another company sees in you. Once you’ve given your 2-weeks notice your employer decides you’re worth investing

Read More »

Biotech Companies are Expanding the Frontiers of Engineered Cell Therapy

Via: https://www.biospace.com/article/biotech-companies-are-expanding-the-frontiers-of-engineered-cell-therapy-/ Published: Nov 11, 2021 By Maggie Chen The plasticity of a cell is one of its quietly profound advantages – picture cells glowing from an extraneous DNA vector incorporated into the genome or cells that acquire newfound targeting abilities to find and kill problematic

Read More »
Clinical Catch-Up: December 11-17

First-of-its-Kind Preventive Breast Cancer Vaccine Study

Via: https://www.biospace.com/article/trial-for-world-s-first-potential-vaccine-for-breast-cancer-begins/ Published: Oct 27, 2021 By Vanessa Doctor, RN Researchers at the Cleveland Clinic are set to launch the Phase I trial for what could be the first-ever vaccine to prevent triple-negative breast cancer. The decision to move forward with the trial comes on the heels of the

Read More »

Life Sciences Industry in California Defies Pandemic-Driven Employment Downturn

Via: https://www.biospace.com/article/life-science-industry-in-california-defies-pandemic-driven-employment-downturn/ Published: Oct 20, 2021 By Kaylei Whalen Since the advent of the COVID-19 pandemic, economic struggle and new work-life balances have hallmarked the American experience. Increasing rates of resignation as a result of staffing shortages and burnout have forced employers to make major changes in workplaces across

Read More »

BioSpace Movers & Shakers, October 15th

Via: https://www.biospace.com/article/biospace-movers-shakers-oct-15/ Published: Oct 15, 2021 By Alex Keown Biopharma and life sciences companies strengthen their leadership teams and executive boards with these Movers & Shakers.  Reneo Pharmaceuticals – Ashley F. Hall was named chief development officer at California-based Reneo Pharmaceuticals. Hall will oversee nonclinical and clinical

Read More »
New Study Finds Freenome’s Multiomics Approach Successful in Detecting Pancreatic Cancer

New Study Finds Freenome’s Multiomics Approach Successful in Detecting Pancreatic Cancer

Via: https://www.biospace.com/article/releases/new-study-finds-freenome-s-multiomics-approach-successful-in-detecting-pancreatic-cancer/ Published: Sep 29, 2021 SOUTH SAN FRANCISCO, Calif., Sept. 29, 2021 /PRNewswire/ — Freenome, a privately-held biotech company, presented new research today at the American Association of Cancer Research (AACR) Special Conference on Pancreatic Cancer. The data demonstrated the potential of extending Freenome’s multiomics approach into other

Read More »
Companies Present Exciting News at ESMO 2021

Five Companies Present Exciting News at ESMO 2021

Via: https://www.biospace.com/article/exciting-clinical-news-out-of-the-european-society-for-medical-oncology-congress-2021 |Published: Sep 17, 2021 By Mark Terry Biopharma companies big and small are presenting exciting clinical studies at the European Society for Medical Oncology Congress 2021. Here’s a look at just some of those highlights: Amgen announced the first combination study results from the Phase Ib/II

Read More »
What's Next for COVID-19? All Signs Point to Boosters

FDA and CDC Expected to Recommend COVID-19 Boosters

Via: https://www.biospace.com/article/covid-19-us-expected-to-recommend-boosters-and-more/ Published: Aug 17, 2021 By Mark Terry What’s Next for COVID-19? All Signs Point to Boosters As COVID-19 surges to earlier pandemic levels in the U.S., federal health officials are expected to authorize a third booster shot eight months after receiving the second of

Read More »
clinical news

Clinical Catch-Up: July 26-30

Via: https://www.biospace.com/article/clinical-catch-up-july-26-30/ With the Alzheimer’s Association International Conference (AAIC) conference last week, there were plenty of clinical trial news and updates. Here’s a look. COVID-19-Related Claritas Pharmaceuticals reported that a study led by clinicians at Royal Brompton & Harefield NHS Foundation Trust validated the potential of its

Read More »

6 Ways to Develop Employees and Grow Your Own Talent

There is much to be said for the benefits of developing employees internally. Not only will you have a happier, more engaged, and longer-tenured workforce than if you did not provide these opportunities for growth, but you can also save a fair amount of money

Read More »

Clinical Catch-Up: July 12-16

Published: Jul 19, 2021 By Mark Terry Via: https://www.biospace.com/article/clinical-catch-up-july-12-16/ It was a moderately busy mid-summer week for clinical trial news. Here’s a look. COVID-19-Related ARCA biopharma provided an update on its Phase IIb ASPEN-COVID-19 trial of rNAPc2 for hospitalized COVID-19 patients. It has received approval from regulators

Read More »

How to Overcome Career Burnout and Stay Motivated

Burnout is defined as a feeling in which you feel so overwhelmed that you are not able to do the things that you had once loved and cared about. Unsurprisingly, the rates of burnout have risen exponentially since the beginning of the pandemic. The primary

Read More »
Noting Delta Variant, Pfizer/BioNTech Plan to Ask FDA for Booster Shot EUA

Pfizer, BioNTech to seek authorization for COVID booster shot as Delta variant spreads

via: https://www.biospace.com/article/noting-delta-variant-pfizer-biontech-plan-to-ask-fda-for-eua-for-booster-shot/ Published: Jul 09, 2021 By Mark Terry Pfizer and BioNTech report a plan to request Emergency Use Authorization (EUA) for third booster shots for their COVID-19 vaccine. The two companies cited initial data from a clinical trial that showed a booster dose given six months

Read More »

New CEOs Named at Two Biopharma Companies

via: https://www.biospace.com/article/new-ceos-named-at-two-top-pharma-companies Published: Jul 08, 2021 By Vanessa Doctor, RN Two chief executive officers (CEOs) were named to biotech and pharmaceutical companies today. Boston-based oncology company Scorpion Therapeutics has announced the appointment of a new chief executive offer to help drive the firm’s cancer care programs. Dr. Axel Hoos joins the company

Read More »

7 Reasons Why Summer is a Great Time to Job Hunt

Think the summer is a bad time for job searching? Guess again! Oddly enough, job seekers are under the impression that searching for a new position during the summer months is a bad idea. What they don’t know, is that companies are filling positions at

Read More »
Clinical Catch-Up: January 10-14

Roche Presents Positive Clinical Data for Neurology Programs at EAN Annual Meeting

via: https://www.biospace.com/article/roche-presents-positive-clinical-data-for-neurology-programs-at-ean-annual-meeting/ Roche presented results from several Phase II and III trials at the 7th Congress of the European Academy of Neurology (EAN) Annual Meeting held virtually June 19-22. Some of the results specifically underscored the efficacy and safety of EVRYSDI™ (risdiplam) for motor neuron disease, Enspryng® (satralizumab)

Read More »
Clinical Catch-Up: December 11-17

Amgen Reunites With Kyowa Kirin in $400 Million Atopic Dermatitis Deal

Via: https://www.biospace.com/article/amgen-reunites-with-kyowa-kirin-to-develop-atopic-dermatitis-drug-in-400-million-deal/?s=69 Amgen reunited with longtime developmental partner Japan’s Kyowa Kirin to develop a Phase III-ready atopic dermatitis treatment. This morning, California-based Amgen announced it will make a $400 million upfront payment to Kyowa Kirin to partner on the development and potential commercialization of KHK4083, the company’s potential first-in-class

Read More »
Clinical catch up

Clinical Catch-Up- May 2021

COVID-19-Related Biophytiscompleted recruitment of 155 patients to its COVA Phase II/III trial of Sarconeos in COVID-19 patients. This will allow the independent Data Monitoring Committee to run its second interim analysis. Sarconeos is an oral, small molecule being developed for sarcopenia in a Phase II trial,

Read More »
BioAge Picks Up Muscle-Aging Program From Amgen

BioAge Licenses Amgen Drug To Treat Muscle Aging

Via: https://www.fiercebiotech.com/biotech/bioage-picks-up-muscle-aging-program-from-amgen-bringing-pipeline-count-to-3 BioAge Labs is adding a third program to its pipeline. The new treatment, licensed from Amgen, is designed to combat muscle aging and could be useful in helping older people recover from surgery more quickly, decreasing muscle atrophy after a long hospital stay

Read More »
5 EMPLOYER TIPS FOR WORKING WITH A STAFFING AGENCY

5 EMPLOYER TIPS FOR WORKING WITH A STAFFING AGENCY

If you have never worked with a staffing firm before, here are 5 tips to have a successful experience: Timing, timing, timing. Respond quickly to an agency’s telephone call or email!  Time is of the essence as the agency may be competing to get their

Read More »
Google Maps will start showing you slower routes. Here’s why

How Google Maps is Becoming Eco-friendly!

Google Maps will start directing drivers to routes it calculates to be the most eco-friendly based on a list of factors. The search engine said it will highlight journeys that generate the lowest carbon footprint instead of showing you the fastest route from point A

Read More »
5 Virtual Interview Tips For Job Seekers

5 Virtual Interview Tips For Job Seekers

First of all, congratulations on landing the interview! Whether it’s your dream position or you’re just getting to know the company, the hard part is over. Now it’s time to prepare for something you’re maybe not used to- a virtual interview! Here are 5 tips

Read More »
5 Job Hunting Tips To Turn Your Search Around

7 Job Hunting Tips To Turn Your Search Around

Finding the right job opportunities and standing out in a competitive market is tough. Too many professionals are unsure how to effectively look for a new job, since there are so many resources out there and so many steps to take. The good news is you can

Read More »
Here are five social media mistakes that could really slow down your job search

Five Social Media Mistakes That Will Hurt Your Job Search

As social media continues to gain normalcy, people filter their tweets and posts less and less, while potential employers are checking out social profiles more and more. Unfortunately, today making big mistakes that are seen by the whole world is extremely easy, particularly if something

Read More »
The Biggest Technology Trends In 2021

10 Technology Trends To Look Out For In 2021

via: https://www.inc.com/anis-uzzaman/top-business-technology-trends-in-2021.html By: Anis Uzzaman, General Partner and CEO, Pegasus Tech Ventures 2020’s Covid-19 pandemic has helped us all become acquainted with uncertainty. Companies are in a hurry to develop new digital capabilities in an effort to build resilience and retool for the post-pandemic world. Here

Read More »
COVID-19’s Impact on Biopharma Mergers & Acquisitions in 2020

COVID-19’s Impact on Biopharma Mergers & Acquisitions in 2020

Most reports indicate that 2020 was not a particularly good year for mergers and acquisitions (M&As) in the biopharma industry.  There’s also some disagreement on numbers which can be related to how they are defining sectors; healthcare versus biotech and pharmaceutical, for example.  Here’s a

Read More »

It’s The Best Time Of The Year To Give Back!

2020 is almost over but before we wave goodbye, R&D Partners wanted to give back to charities near and dear to us. We asked our employees to pick a foundation and make a donation. Here’s a list of all the amazing places we were able

Read More »

Success of U.S. COVID-19 Strategy Relies on Vaccines from Multiple Companies

Via: https://www.biospace.com/article/u-s-government-banks-on-vaccines-from-multiple-companies-to-end-pandemic/ Published: Dec 09, 2020 By Alex Keown The U.S. Food and Drug Administration (FDA) is on the cusp of approving the first vaccines against the novel coronavirus, delivering a potential end to the pandemic. Although vaccines will be available pending approval, there are questions

Read More »

3 Things to Consider When Choosing a Staffing Agency

A staffing partner can be an incredibly valuable asset for businesses hoping to find the best talent. However, not all recruiters are created equal and you will only be as successful as the firm you choose to partner with. Here are 3 tips you can use

Read More »

Amazon Gets Closer to Drone Delivery with FAA Approval

Via: https://www.cnn.com/2020/08/31/tech/amazon-drone-faa-approval/index.html Washington, DC (CNN)Amazon received a critical certificate from the Federal Aviation Administration on Saturday, bringing it a step closer to launching drone delivery in the United States. Amazon (AMZN) now has what’s called a Part 135 air carrier certificate, which must be held before a company begins

Read More »
AstraZeneca Expands Phase III

AstraZeneca Expands Phase III COVID-19 Vaccine Trial into the U.S.

Via: https://www.biospace.com/article/astrazeneca-expands-phase-iii-covid-19-vaccine-trial-into-the-u-s-/ AstraZeneca announced that its Phase III clinical trial of its COVID-19 vaccine  candidate, AZD1222, is expanding into the U.S. It will be dubbed D8110C00001 and is funded by the Biomedical Advanced Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID). The

Read More »